Daniel Tillett
Vermögen: 38 Mio $ am 31.05.2026
Vermögen: 38 Mio $ am 31.05.2026
Dr. Daniel Tillett is a Chief Executive Officer, MD & Director at Racura Oncology Ltd. He is on the Board of Directors at Entropy Neurodynamics Ltd. and Racura Oncology Ltd. Dr. Tillett was previously employed as a Non-Executive Director by Simble Solutions Ltd., an Executive Director & Chief Scientific Officer by Race Oncology Ltd., and a Chief Executive Officer by Nucleics Ltd. He received his undergraduate degree from School of Biotechnology & Biomolecular Sciences and a doctorate degree from School of Biotechnology & Biomolecular Sciences.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 10,64 % | 28.05.2026 | 20 269 351 ( 10,64 % ) | 38 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RACURA ONCOLOGY LTD | Vorstandsvorsitzender | 22.11.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Direktor/Vorstandsmitglied | 03.07.2023 |
| RACURA ONCOLOGY LTD | Technik-/Wissenschafts-/F&E-Leiter | 23.03.2023 |
Nucleics Ltd. | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Simble Solutions Ltd.
Simble Solutions Ltd. Packaged SoftwareTechnology Services Develops software for enterprises to manage business and resources | Technology Services |
School of Biotechnology & Biomolecular Sciences
School of Biotechnology & Biomolecular Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleics Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen